(RNO) Renault - Ratings and Ratios
Passenger Cars, Light Commercial Vehicles, Electric Vehicles, Used Vehicles, Spare Parts
| Risk via 10d forecast | |
|---|---|
| Volatility | 30.0% |
| Value at Risk 5%th | 48.2% |
| Reward | |
|---|---|
| Sharpe Ratio | -0.32 |
| Alpha | -25.38 |
| Character | |
|---|---|
| Hurst Exponent | 0.476 |
| Beta | 0.872 |
| Drawdowns 3y | |
|---|---|
| Max DD | 39.51% |
| Mean DD | 16.09% |
Description: RNO Renault October 30, 2025
Renault SA (ticker RNO) is a French multinational that designs, manufactures, sells, repairs, maintains and leases motor vehicles across Europe, Eurasia, Africa, the Middle East, Asia-Pacific and the Americas. Its operations are organized into three segments: Automotive (passenger cars, light commercial vehicles and related parts), Sales Financing (credit, rental, maintenance and service contracts under the Mobilize Financial Services brand) and Mobility Services (electric-vehicle charging, energy solutions and other services under the Mobilize Beyond Automotive brand). The group also markets used cars, spare parts, and conducts B2B powertrain, research and advanced-engineering activities under the Renault, Dacia, Alpine, Renault Korea Motors and Mobilize brands.
Key recent metrics show Renault generated €46 billion of revenue in 2023, with EV sales rising 45 % year-on-year and the company now targeting 30 % of total sales to be electric by 2025. The firm’s exposure to the European Union’s tightening CO₂-emission standards and the ongoing semiconductor shortage are material economic drivers, while its strategic alliance with Nissan-Mitsubishi provides a platform for shared platforms and cost synergies that help offset margin pressure. In the European passenger-car market Renault holds roughly a 12 % market share, making it the region’s second-largest manufacturer after Volkswagen.
For a deeper, data-driven look at Renault’s valuation and risk profile, see the analysis on ValueRay.
RNO Stock Overview
| Market Cap in USD | 11,584m |
| Sub-Industry | Automobile Manufacturers |
| IPO / Inception | |
| Return 12m vs S&P 500 | -23.1% |
| Analyst Rating | - |
RNO Dividends
| Dividend Yield | 6.35% |
| Yield on Cost 5y | 8.80% |
| Yield CAGR 5y | 640.00% |
| Payout Consistency | 69.2% |
| Payout Ratio | 68.0% |
RNO Growth Ratios
| CAGR | 2.76% |
| CAGR/Max DD Calmar Ratio | 0.07 |
| CAGR/Mean DD Pain Ratio | 0.17 |
| Current Volume | 878.3k |
| Average Volume | 905.2k |
Piotroski VR‑10 (Strict, 0-10) 5.5
| Net Income (-10.33b TTM) > 0 and > 6% of Revenue (6% = 6.56b TTM) |
| FCFTA 0.05 (>2.0%) and ΔFCFTA 3.13pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 2.10% (prev 10.71%; Δ -8.62pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.09 (>3.0%) and CFO 11.02b > Net Income -10.33b (YES >=105%, WARN >=100%) |
| NO Net Debt/EBITDA fails (EBITDA <= 0) |
| Current Ratio 1.03 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (273.5m) change vs 12m ago -0.83% (target <= -2.0% for YES) |
| Gross Margin 19.12% (prev 18.37%; Δ 0.74pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 92.38% (prev 70.70%; Δ 21.68pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio -8.70 (EBITDA TTM -29.0m / Interest Expense TTM 651.0m) >= 6 (WARN >= 3) |
Altman Z'' -0.33
| (A) 0.02 = (Total Current Assets 88.20b - Total Current Liabilities 85.91b) / Total Assets 116.94b |
| (B) -0.10 = Retained Earnings (Balance) -11.19b / Total Assets 116.94b |
| (C) -0.05 = EBIT TTM -5.67b / Avg Total Assets 118.43b |
| (D) 0.17 = Book Value of Equity 16.43b / Total Liabilities 96.29b |
| Total Rating: -0.33 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 43.61
| 1. Piotroski 5.50pt = 0.50 |
| 2. FCF Yield 7.55% = 3.77 |
| 3. FCF Margin 5.07% = 1.27 |
| 4. Debt/Equity 3.52 = -1.50 |
| 5. Debt/Ebitda data missing |
| 6. ROIC - WACC (= -7.50)% = -9.38 |
| 7. RoE -37.40% = -2.50 |
| 8. Rev. Trend 57.27% = 4.30 |
| 9. EPS Trend -57.00% = -2.85 |
What is the price of RNO shares?
Over the past week, the price has changed by +0.49%, over one month by +0.84%, over three months by +6.95% and over the past year by -11.38%.
Is Renault a good stock to buy?
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of RNO is around 46.71 EUR . This means that RNO is currently undervalued and has a potential upside of +34.92% (Margin of Safety).
Is RNO a buy, sell or hold?
What are the forecasts/targets for the RNO price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 46.6 | 34.5% |
| Analysts Target Price | - | - |
| ValueRay Target Price | 50.9 | 47.1% |
RNO Fundamental Data Overview January 01, 1970
Market Cap EUR = 10.04b (10.04b EUR * 1.0 EUR.EUR)
P/E Forward = 6.5574
P/S = 0.1763
P/B = 0.5217
P/EG = 0.8055
Beta = 0.872
Revenue TTM = 109.40b EUR
EBIT TTM = -5.67b EUR
EBITDA TTM = -29.0m EUR
Long Term Debt = 5.49b EUR (from longTermDebt, last quarter)
Short Term Debt = 64.05b EUR (from shortTermDebt, last quarter)
Debt = 70.08b EUR (from shortLongTermDebtTotal, last quarter)
Net Debt = 51.15b EUR (from netDebt column, last quarter)
Enterprise Value = 73.52b EUR (10.04b + Debt 70.08b - CCE 6.60b)
Interest Coverage Ratio = -8.70 (Ebit TTM -5.67b / Interest Expense TTM 651.0m)
FCF Yield = 7.55% (FCF TTM 5.55b / Enterprise Value 73.52b)
FCF Margin = 5.07% (FCF TTM 5.55b / Revenue TTM 109.40b)
Net Margin = -9.44% (Net Income TTM -10.33b / Revenue TTM 109.40b)
Gross Margin = 19.12% ((Revenue TTM 109.40b - Cost of Revenue TTM 88.49b) / Revenue TTM)
Gross Margin QoQ = 17.69% (prev 18.62%)
Tobins Q-Ratio = 0.63 (Enterprise Value 73.52b / Total Assets 116.94b)
Interest Expense / Debt = 0.24% (Interest Expense 170.0m / Debt 70.08b)
Taxrate = -2.99% (negative due to tax credits) (324.0m / -10.82b)
NOPAT = -5.83b (EBIT -5.67b * (1 - -2.99%)) [loss with tax shield] [negative tax rate / tax credits]
Current Ratio = 1.03 (Total Current Assets 88.20b / Total Current Liabilities 85.91b)
Debt / Equity = 3.52 (Debt 70.08b / totalStockholderEquity, last quarter 19.88b)
Debt / EBITDA = -1764 (out of range, set to none) (Net Debt 51.15b / EBITDA -29.0m)
Debt / FCF = 9.22 (Net Debt 51.15b / FCF TTM 5.55b)
Total Stockholder Equity = 27.61b (last 4 quarters mean from totalStockholderEquity)
RoA = -8.83% (Net Income -10.33b / Total Assets 116.94b)
RoE = -37.40% (Net Income TTM -10.33b / Total Stockholder Equity 27.61b)
RoCE = -17.11% (EBIT -5.67b / Capital Employed (Equity 27.61b + L.T.Debt 5.49b))
RoIC = -6.13% (negative operating profit) (NOPAT -5.83b / Invested Capital 95.25b)
WACC = 1.37% (E(10.04b)/V(80.11b) * Re(9.23%) + D(70.08b)/V(80.11b) * Rd(0.24%) * (1-Tc(-0.03)))
Discount Rate = 9.23% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -2.96%
[DCF Debug] Terminal Value 77.68% ; FCFE base≈4.10b ; Y1≈5.06b ; Y5≈8.63b
Fair Price DCF = 407.5 (DCF Value 118.14b / Shares Outstanding 289.9m; 5y FCF grow 25.0% → 3.0% )
EPS Correlation: -57.00 | EPS CAGR: -93.97% | SUE: -4.0 | # QB: 0
Revenue Correlation: 57.27 | Revenue CAGR: 11.50% | SUE: 0.91 | # QB: 1